UNSW Sydney medical researchers create a new diagnostic method for Parkinson’s disease that combines a single-molecule counting technique with a rapid amplification assay to detect alpha-synuclein – a promising biomarker for the disease. This technique will allow clinicians to detect Parkinson’s disease at early stages before the onset of clinical signs, which will lead to better outcomes for the patients.

Brisbane-based gut microbiome Biotech Company, Microba, have partnered with researchers from The University of Queensland’s Faculty of Medicine to develop new treatments and biomarkers for Parkinson’s disease by targeting the gut microbiome

A new approach to focused ultrasound (FUS) for Parkinson’s is in the news. FUS is a non-invasive procedure that carefully concentrates ultrasound waves to destroy brain cells involved in Parkinson’s.